{"id":69,"date":"2012-11-21T10:20:45","date_gmt":"2012-11-21T10:20:45","guid":{"rendered":"http:\/\/www.farmacovigilanciacanarias.org\/noticias\/?p=69"},"modified":"2012-11-21T10:25:40","modified_gmt":"2012-11-21T10:25:40","slug":"aemps-adhesivos-de-fibrina-2","status":"publish","type":"post","link":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/2012\/11\/21\/aemps-adhesivos-de-fibrina-2\/","title":{"rendered":"AEMPS: Adhesivos de fibrina."},"content":{"rendered":"<p>Nota informativa:<\/p>\n<p>&#8211; \u00a0Categor\u00eda: MEDICAMENTOS USO HUMANO, SEGURIDAD.<br \/>\n&#8211; \u00a0Referencia: MUH (FV), 16\/2012 , de 20\/11\/12<\/p>\n<p><a href=\"http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/2012\/NI-MUH_FV_16-2012.htm\">Adhesivos de fibrina: nuevas contraindicaciones y precauciones de uso en su aplicaci\u00f3n por pulverizaci\u00f3n<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nota informativa: &#8211; \u00a0Categor\u00eda: MEDICAMENTOS USO HUMANO, SEGURIDAD. &#8211; \u00a0Referencia: MUH (FV), 16\/2012 , de 20\/11\/12 Adhesivos de fibrina: nuevas contraindicaciones y precauciones de uso en su aplicaci\u00f3n por pulverizaci\u00f3n<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,4],"tags":[],"class_list":["post-69","post","type-post","status-publish","format-standard","hentry","category-alertas","category-seguridad"],"_links":{"self":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/69","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/comments?post=69"}],"version-history":[{"count":4,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/69\/revisions"}],"predecessor-version":[{"id":72,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/69\/revisions\/72"}],"wp:attachment":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/media?parent=69"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/categories?post=69"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/tags?post=69"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}